Additionally, piR-55,490 inhibits lung carcinoma growth via the mTOR pathway [23], and piR-651 promotes apoptosis in non-small cell lung cancer (NSCLC) [24]. This evidence concerns the gene MTOR and non-small cell lung carcinoma.